KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Globus Medical (GMED) Net Margin (2016 - 2025)

Globus Medical's Net Margin history spans 15 years, with the latest figure at 17.01% for Q4 2025.

  • For Q4 2025, Net Margin rose 1298.0% year-over-year to 17.01%; the TTM value through Dec 2025 reached 18.3%, up 1422.0%, while the annual FY2025 figure was 18.3%, 1421.0% up from the prior year.
  • Net Margin reached 17.01% in Q4 2025 per GMED's latest filing, up from 15.47% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 27.22% in Q2 2025 to a low of 1.18% in Q1 2024.
  • Average Net Margin over 5 years is 13.46%, with a median of 16.53% recorded in 2021.
  • The largest YoY upside for Net Margin was 3054bps in 2021 against a maximum downside of -2707bps in 2021.
  • A 5-year view of Net Margin shows it stood at 7.81% in 2021, then soared by 153bps to 19.78% in 2022, then crashed by -88bps to 2.44% in 2023, then soared by 65bps to 4.03% in 2024, then skyrocketed by 322bps to 17.01% in 2025.
  • Per Business Quant, the three most recent readings for GMED's Net Margin are 17.01% (Q4 2025), 15.47% (Q3 2025), and 27.22% (Q2 2025).